Menu
Back to Journals » Cancer Management and Research » Volume 11
RETRACTED ARTICLE: iNOS is associated with tumorigenicity as an independent prognosticator in human intrahepatic cholangiocarcinoma
Authors Liu S , Jiang J, Huang L, Jiang Y, Yu N, Liu X, Lv Y, Li H, Zou L, Peng C, Yu X, Jiang B
Received 14 March 2019
Accepted for publication 12 July 2019
Published 26 August 2019 Volume 2019:11 Pages 8005—8022
DOI https://doi.org/10.2147/CMAR.S208773
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Eileen O'Reilly
This paper has been retracted.
Liu S, Jiang J, Huang L, et al. Cancer Manag Res. 2019;11:8005–8022.
We, the Editors and Publisher of Cancer Management and Research, have retracted the published article. Concerns were raised following the authors request to correct Figure 4. It was found images in Figure 4 had been duplicated. Specifically,
- The images for Figure 4C, 0h, 0 µmol/l and 25 µmol/l, have been duplicated.
When approached for an explanation, the authors were cooperative and provided some original data for their study, however, the provided data was not satisfactory, and the results could not be adequately verified. As verifying the validity of the published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors do not agree with this decision.
We have been informed in our decision-making by our editorial policies and the COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2019 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.